Volume 66, Issue 4 pp. 373-377
Full Access

Loss of the N-myc oncogene in a patient with a small interstitial deletion of the short arm of chromosome 2

Howard M. Saal

Corresponding Author

Howard M. Saal

Division of Human Genetics, The Children's Hospital Research Foundation, Children's Hospital Medical Center, Cincinnati, Ohio

Division of Human Genetics, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229Search for more papers by this author
Lora J. King

Lora J. King

Genetics and IVF Institute, Fairfax, Virginia

Search for more papers by this author
Donna Zimmerman

Donna Zimmerman

Imagenetics, Naperville, Illinois

Search for more papers by this author
Robert C. Johnson

Robert C. Johnson

Department of Medical Genetics, Children's National Medical Center, Department of Pediatrics, The George Washington University School of Medicine, Washington, DC

Search for more papers by this author
Ann G. Carr

Ann G. Carr

Department of Medical Genetics, Children's National Medical Center, Department of Pediatrics, The George Washington University School of Medicine, Washington, DC

Search for more papers by this author
Carole A. Samango-Sprouse

Carole A. Samango-Sprouse

Department of Medical Genetics, Children's National Medical Center, Department of Pediatrics, The George Washington University School of Medicine, Washington, DC

Search for more papers by this author
Wayne Stanley

Wayne Stanley

Genetics and IVF Institute, Fairfax, Virginia

Search for more papers by this author

Abstract

To our knowledge, only four previous cases of distal chromosome 2p deletions exist in the literature. We present a patient with minor facial anomalies who had a distal interstitial deletion of the short arm of chromosome 2, del(2)(p24.2p25.1). This patient had many features seen in other patients with distal 2p deletion including short stature, “rectangular” facies, microcephaly, hypotonia, and mental retardation. This patient also has sensorineural hearing loss which has been described in one other patient with a similar deletion. The N-myc oncogene has been mapped to 2p24. By fluorescence in situ hybridization using a cDNA probe for the N-myc oncogene, this patient was found to have a deletion of the N-myc oncogene. This confirms the previous map location for N-myc. © 1996 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.